Enhanced endothelial barrier protective and anti-inflammatory effects by synthetic iloprost-conjugated phospholipid.

K. Birukov (Baltimore, United States of America), O. Oskolkova (Chicago, United States of America), Y. Li (Baltimore, United States of America), C. Zhang (Baltimore, United States of America), G. Gawlak (Chicago, United States of America), Y. Ke (Baltimore, United States of America), A. Birukova (Baltimore, United States of America)

Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Session: Triggers of acute lung injury: mechanical ventilation and oxygen levels
Session type: Thematic Poster
Number: 4307
Disease area: Pulmonary vascular diseases, Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Birukov (Baltimore, United States of America), O. Oskolkova (Chicago, United States of America), Y. Li (Baltimore, United States of America), C. Zhang (Baltimore, United States of America), G. Gawlak (Chicago, United States of America), Y. Ke (Baltimore, United States of America), A. Birukova (Baltimore, United States of America). Enhanced endothelial barrier protective and anti-inflammatory effects by synthetic iloprost-conjugated phospholipid.. 4307

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mechanisms of vascular endothelial cell injury in response to intermittent and continuous hypoxia exposure and protective effects of anti-inflammatory and anti-oxidant agents
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019

In vitro effects of vasodilatory drugs on BMPR2-silenced pulmonary microvascular endothelial cell function
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017


Inhibitory effect of statins on fibrogenic mediator production from lung cells
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Esterification of iloprost enhances its protective effects on pulmonary endothelium
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Beneficial effects of HDAC6 inhibition on airway epithelial barrier function
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019


Inhibitory capacity of different steroids on neutrophil migration across a bilayer of endothelial and bronchial epithelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 431s
Year: 2001

Defect of sirtuin, an anti-aging molecule, reduces anti-oxidative stress capacity in THP-1 cell line
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010


Anti-inflammatory properties of synthetic and endogenous Rev-Erb-alpha agonists.
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


MSC extracellular vesicles modulate human macrophages in ARDS towards anti-inflammatory phenotype via transfer of miRNA181-a and PTEN-pSTAT5-SOCS1 signalling
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



Anti-inflammatory and anti-oxidative activity of YPL-001 in human bronchial epithelial cells
Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Year: 2017

Mechanisms of acetylcholine-induced release of proinflammatory extracellular vesicles by endothelial cells and inhibitory effects of tiotropium
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019


Oxidized phospholipids exhibit protective effects against ventilator-induced vascular leak and inflammation
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008


Late Breaking Abstract - Anti-inflammatory and anti-fibrotic effect of novel, pan-PDE inhibitors in human bronchial epithelial cells
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020


Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019


Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015

Bioengineered nanoparticles targeted to mesenchymal cells from patients with BOS exert anti-inflammatory activity
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017

The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2008 - Airway cell biology
Year: 2008


The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010